Birth weight variants are associated with variable fetal intrauterine growth from 20 weeks of gestation

Scientific Reports
L EngelbrechtsenH Vestergaard

Abstract

Fetal intrauterine growth is influenced by complex interactions between the maternal genes, environment and fetal genes. The aim of this study was to assess the effect of GWAS-identified genetic variants associated with birth weight on intrauterine fetal growth in 665 children. Fetal growth was estimated by two-dimensional ultrasound scans at 20, 25 and 32 weeks of gestation and growth trajectories were modeled using mixed linear regression. A genetic risk score (GRS) of birth weight-raising variants was associated with intrauterine growth showing an attenuating effect on the unconditional daily reduction in proportional weight gain of 8.92 × 10-6 percentage points/allele/day (p = 2.0 × 10-4), corresponding to a mean difference of 410 g at 40 weeks of gestation between a child with lowest and highest GRS. Eight variants were independently associated with intrauterine growth throughout the pregnancy, while four variants were associated with fetal growth in the periods 20-25 or 25-32 weeks of gestation, indicating that some variants may act in specific time windows during pregnancy. Four of the intrauterine growth variants were associated with type 2 diabetes, hypertension or BMI in the UK Biobank, which may provide basis for fur...Continue Reading

References

Oct 1, 1991·Radiology·F P HadlockJ Martinez-Poyer
Oct 26, 1991·BMJ : British Medical Journal·C N HalesP D Winter
Jul 14, 1998·Nature Genetics·A T HattersleyS Ellard
Aug 21, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·B ClaussonS Cnattingius
Mar 25, 2006·Endocrinology·Amanda N Sferruzzi-PerriClaire T Roberts
May 16, 2007·American Journal of Human Genetics·Rachel M FreathyTimothy M Frayling
Jan 31, 2008·Frontiers of Hormone Research·Peter D GluckmanDavid Raubenheimer
Jul 4, 2008·The New England Journal of Medicine·Peter D GluckmanKent L Thornburg
Nov 22, 2008·American Journal of Hypertension·Charmaine S WrightEmily Oken
Dec 9, 2008·Nature Genetics·Inga ProkopenkoGonçalo R Abecasis
May 7, 2009·The Journal of Clinical Endocrinology and Metabolism·Tine D ClausenPeter Damm
Jan 27, 2010·Pediatrics·Irene E OlsenBabette S Zemel
May 1, 2010·American Journal of Obstetrics and Gynecology·Thomas R Moore
Jun 29, 2010·Nature Genetics·Benjamin F VoightUNKNOWN GIANT Consortium
Nov 29, 2012·Current Diabetes Reports·Mina DesaiMichael G Ross
Dec 4, 2012·Nature Genetics·Momoko HorikoshiUNKNOWN Early Growth Genetics (EGG) Consortium
May 4, 2013·Seminars in Fetal & Neonatal Medicine·F H BloomfieldJ E Harding
May 28, 2014·Acta Obstetricia Et Gynecologica Scandinavica·Dorte Gybel-BraskLillian Skibsted
Feb 13, 2015·Nature·Adam E LockeElizabeth K Speliotes
Jan 30, 2016·Clinical Epigenetics·Aamod R NawatheVasso Terzidou
Mar 16, 2016·JAMA : the Journal of the American Medical Association·Jessica TyrrellUNKNOWN Early Growth Genetics (EGG) Consortium
Jul 28, 2016·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Dorte Gybel-BraskEstrid V S Høgdall
Sep 30, 2016·Nature·Momoko HorikoshiRachel M Freathy
Mar 16, 2017·Current Diabetes Reports·Robin N BeaumontRachel M Freathy
Jun 2, 2017·Diabetes·Robert A ScottUNKNOWN DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium
Nov 7, 2017·Pregnancy Hypertension·Tai-Ho HungSzu-Fu Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
SGA
genotyping

Clinical Trials Mentioned

NCT00836524

Software Mentioned

R
GenomeStudio
GIANT

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.